This is a Validated Antibody Database (VAD) review about human MRP3, based on 4 published articles (read how Labome selects the articles), using MRP3 antibody in all methods. It is aimed to help Labome visitors find the most suited MRP3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
MRP3 synonym: ABC31; EST90757; MLP2; MOAT-D; MRP3; cMOAT2

Santa Cruz Biotechnology
mouse monoclonal (M3II-21)
  • immunohistochemistry; human; 1:150; loading ...; fig 5a
Santa Cruz Biotechnology MRP3 antibody (SantaCruz, sc-59612) was used in immunohistochemistry on human samples at 1:150 (fig 5a). J Clin Med (2022) ncbi
mouse monoclonal (M3II-21)
  • flow cytometry; human; 1:100; fig 1b
Santa Cruz Biotechnology MRP3 antibody (Santa Cruz, M3II-21) was used in flow cytometry on human samples at 1:100 (fig 1b). Curr Cancer Drug Targets (2016) ncbi
Abcam
mouse monoclonal (M3II-9)
  • western blot; human; 1:20; loading ...; fig s4g, s4h
Abcam MRP3 antibody (abcam, ab3375) was used in western blot on human samples at 1:20 (fig s4g, s4h). Front Oncol (2021) ncbi
Invitrogen
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 3, 4
In order to study ABCC3 overexpression and drug resistance, cell proliferation, and aerobic glycolysis and its association with bladder cancer patients, Invitrogen MRP3 antibody (Thermo Fisher, PA5-23653) was used in western blot on human samples at 1:1000 (fig 3, 4). Tumour Biol (2016) ncbi
Articles Reviewed
  1. Malinowski D, Grzeg xf3 x142 kowski P, Piotrowska K, S x142 ojewski M, Dro x17a dzik M. Membrane Transporters and Carriers in Human Seminal Vesicles. J Clin Med. 2022;11: pubmed publisher
  2. Ding B, Bao C, Jin L, Xu L, Fan W, Lou W. CASK Silence Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Through Activating Apoptosis and Autophagic Cell Death. Front Oncol. 2021;11:681683 pubmed publisher
  3. Liu X, Yao D, Liu C, Cao Y, Yang Q, Sun Z, et al. Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients. Tumour Biol. 2016;37:8367-74 pubmed publisher
  4. Fanelli M, Hattinger C, Vella S, Tavanti E, Michelacci F, Gudeman B, et al. Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma. Curr Cancer Drug Targets. 2016;16:261-74 pubmed